These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16173958)

  • 21. Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK.
    Cheung CW; Burton C; Smith P; Linch DC; Hoskin PJ; Ardeshna KM
    Br J Haematol; 2005 Oct; 131(2):193-200. PubMed ID: 16197449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishing a prognostic score for primary CNS lymphomas.
    Ferreri AJ; Reni M
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):303-4; author reply 304-5. PubMed ID: 15629627
    [No Abstract]   [Full Text] [Related]  

  • 23. A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas.
    Kujawski LA; Longo WL; Williams EC; Turman NJ; Brandt N; Mosher DF; Eickhoff JC; Kahl BS
    Cancer Invest; 2007 Mar; 25(2):87-93. PubMed ID: 17453819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case series: CSF LDH, proteins and electrolyte levels in patients of acute lymphocytic leukemia.
    Rao D; Ghalaut VS; Ghalaut PS; Rao S
    Clin Chim Acta; 2012 Jul; 413(13-14):1045-8. PubMed ID: 22387722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversies in the management of central nervous system leukemia.
    Barredo J; Ritchey AK
    Pediatr Hematol Oncol; 2010 Aug; 27(5):329-32. PubMed ID: 20469977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consideration of aggressive therapeutic strategies for primary testicular lymphoma.
    Park BB; Kim JG; Sohn SK; Kang HJ; Lee SS; Eom HS; Kwon HC; Oh SY; Kang JH; Oh SJ; Shin HJ; Suh C; Kim JH; Kim HY; Kim K; Ryoo BY; Kim WS
    Am J Hematol; 2007 Sep; 82(9):840-5. PubMed ID: 17563078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.
    Barredo JC; Devidas M; Lauer SJ; Billett A; Marymont M; Pullen J; Camitta B; Winick N; Carroll W; Ritchey AK
    J Clin Oncol; 2006 Jul; 24(19):3142-9. PubMed ID: 16809737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
    Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
    Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.
    Herrlinger U; Glantz M; Schlegel U; Gisselbrecht C; Cavalli F
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S25-34. PubMed ID: 19660681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
    Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
    J Clin Oncol; 2005 Dec; 23(36):9172-8. PubMed ID: 16361619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum lactate dehydrogenase is an important risk determinant in acute lymphocytic leukemia.
    Fanin R; Zuffa E; Fasola G; Damiani D; Gallizia C; Michieli MG; Marcuzzi P; Russo D; Visani G; Resegotti L
    Haematologica; 1989; 74(2):161-5. PubMed ID: 2501169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of a CNS relapse while on therapy for Burkitt lymphoma.
    Burke MJ; Dayton V
    Pediatr Blood Cancer; 2009 Feb; 52(2):290-2. PubMed ID: 18937319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic progress in acute lymphoblastic leukemias and stage IV Burkitt-type lymphomas in children].
    Leverger G; Patte C
    Bull Acad Natl Med; 2003; 187(4):743-55; discussion 755-7. PubMed ID: 14556479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CNS manifestations of malignancies: case 1. Conjunctival relapse of acute lymphoblastic leukemia heralding pituitary and CNS disease.
    Hon C; Law RW; Shek TW; Au WY
    J Clin Oncol; 2005 Jun; 23(18):4225-6. PubMed ID: 15961769
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of central nervous system relapses in diffuse large B-cell lymphoma: which patients and how?
    Korfel A
    Curr Opin Oncol; 2011 Sep; 23(5):436-40. PubMed ID: 21760506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is the best salvage therapy for treatment of isolated CNS relapse in elderly patients with imatinib-responsive Ph(+) ALL?
    Mele G; Pinna S; Melpignano A; Romano A; Brocca MC; Coppi MR; Quarta G
    Leuk Res; 2007 Oct; 31(10):1445-7. PubMed ID: 17462730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compassionate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukemia: report of 6 cases.
    Sancho JM; Ribera JM; Romero MJ; Martín-Reina V; Giraldo P; Ruiz E
    Haematologica; 2006 Mar; 91(3):ECR02. PubMed ID: 16533729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
    Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
    J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
    Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J
    Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment results of chemoradiation therapy for localized aggressive lymphomas: A retrospective 20-year study.
    Yamashita H; Izutsu K; Nakamura N; Shiraishi K; Chiba S; Kurokawa M; Tago M; Igaki H; Ohtomo K; Nakagawa K
    Ann Hematol; 2006 Aug; 85(8):523-9. PubMed ID: 16691398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.